Clinical Data Foundries are on the horizon

Nelson Advisors
5 days ago
12 min read

The Strategic Evolution of Global Health Systems into Clinical Data Foundries: A 2030 Roadmap for Data Assetisation and Modular AI Architecture

The global healthcare landscape is currently traversing a foundational shift that redefines the essence of the clinical record. Historically, health systems viewed patient documentation as a necessary but cumbersome administrative burden, a repository of past events required primarily for billing, legal compliance and basic clinical continuity.

However, as the industry moves toward a 2030 horizon, these records are being reimagined as active, high-velocity and highly monetised assets. This transformation is not merely a technical upgrade but a major strategic pivot toward the creation of "clinical data foundries." These foundries represent a new organisational form where de-identified patient data spanning complex genomics, unstructured physician notes and longitudinal diagnostic results, is systematically refined, standardised and licensed to pharmaceutical, medtech and technology companies.

The impetus for this shift is rooted in the deep structural challenges facing healthcare providers globally. Rising care costs, chronic labour shortages, and persistent margin compression have exhausted traditional productivity levers.

Consequently, healthcare leaders are turning toward artificial intelligence (AI) and data assetisation to unlock new sources of value. This evolution is characterised by two critical movements: first, the development of a modular, connected AI architecture that replaces fragmented point solutions and second, the establishment of the clinical data foundry as a primary revenue generator and research accelerator. By adopting these frameworks, health systems are positioning themselves as central nodes in a global bio-innovation ecosystem, facilitating drug discovery at unprecedented speeds while stabilising their own financial futures.

The Macro-Economic Imperative: From Cost Centers to Value Engines

The traditional economic model of health systems, predicated on high-volume service delivery, is under extreme duress. In the United States and Europe, operating margins have reached a point where reinvestment in physical infrastructure is becoming difficult, necessitating a pivot toward digital assets that offer higher scalability and margin potential. The transformation into a clinical data foundry allows a health system to transition from a pure "cost centre" focused on clinical throughput to a "value engine" that monetises the insights derived from that throughput.

Economic Driver	Impact on Traditional Health Systems	Role of the Clinical Data Foundry
Labour Shortages	Increased reliance on expensive agency labour; clinician burnout.	Automation of documentation via ambient AI, generating clean data for secondary use.
Margin Compression	Service-line profitability declines; limited capital for innovation.	High-margin licensing of de-identified data assets to life sciences partners.
Rising Care Costs	Inflationary pressure on supplies and technology.	Operational efficiency gains via AI orchestration and predictive staffing.
Research Demand	High cost and long timelines for clinical trials and drug discovery.	Real-world evidence (RWE) generation via longitudinal data cohorts.

The market for these data monetisation solutions is expanding rapidly. Global estimates indicate that the market for data monetisation for healthcare providers was approximately $125.6 Million in 2024, with projections suggesting a rise to $293.1 Million by 2030, representing a compound annual growth rate (CAGR) of 15.3%.

This growth is heavily concentrated in North America, which accounted for over 40% of the revenue share in 2023, driven by a strong regulatory environment (HIPAA) and widespread EHR adoption. Within this market, the software segment remains dominant, as organisations require sophisticated tools to transform raw, unstructured data into "research-ready" assets.

The Evolution of the Electronic Health Record (EHR) Market

The transition to data foundries is fundamentally altering the competitive dynamics of the EHR market. Major incumbents, such as Epic and Cerner, have begun integrating AI capabilities natively, ranging from patient engagement tools to revenue cycle management and clinical trial site selection. This has intensified the pressure on third-party "point solution" vendors, those providing single-task applications, as health systems increasingly favour platform models that promote multivendor interoperability.

Natural selection in the AI healthcare space is accelerating. Solutions with proven traction and frictionless workflows are surviving, while those that add administrative friction are being consolidated. Investors are becoming more selective, prioritising companies that are "integration-ready" and can function as plug-in assets within a broader modular architecture. This shift mirrors the evolution of other mature digital industries, where the value moves from the application layer to the orchestration and data layers.

Modular AI Architecture: The Technical Foundation of the Foundry

The "modular architecture" mentioned in the strategic vision for 2030 represents a departure from monolithic, proprietary systems. In this new paradigm, healthcare organisations assemble their digital infrastructure using several key layers: domain-specific AI models, intelligent agents acting as connectors, and standardised communication protocols. This architecture allows for a "plug-and-play" environment where point solutions are treated as on-ramps rather than permanent silos.

Orchestration and the Model Context Protocol (MCP)

At the heart of the modular architecture lies the orchestration layer, which governs how different AI agents interact with clinical data and with each other. The emergence of the Model Context Protocol (MCP) has provided a standardised framework for this orchestration.

Supported by industry leaders including Anthropic, OpenAI and Microsoft, MCP serves as a "universal plug", analogous to USB-C for hardware, that enables AI agents to connect seamlessly to external tools like EHRs, billing systems and diagnostic databases.

MCP Architectural Layer	Description	Healthcare Application
MCP Client	The AI model (e.g., Claude, GPT-4) initiating requests.	A clinical documentation assistant or a researcher's query agent.
MCP Server	The external tool or data source wrapped in MCP format.	A FHIR server, an imaging archive (PACS), or a lab system.
MCP Gateway	The security and governance layer managing traffic.	Enforces HIPAA compliance, audit trails, and PHI masking.
Context Memory	Preservation of session data across multiple interactions.	Maintaining patient history during a complex diagnostic inquiry.

The technical value of MCP in a healthcare setting is its ability to remove the need for custom code for every integration.By using JSON-RPC 2.0 to structure messages, MCP allows an AI agent to dynamically discover and connect to clinical systems, preserving context across sessions. For a clinical data foundry, this means that data can be accessed in real-time where it resides, rather than requiring the constant movement of massive, sensitive datasets into central repositories.

Implementing MCP Gateways for Governance

Security remains a primary concern when deploying agentic AI in healthcare. Organizations are increasingly adopting MCP Gateways to act as a central security and governance layer. These gateways, such as Keragon, Innovaccer’s HMCP, or MintMCP, handle the complexities of enterprise deployments, including authentication (OAuth wrapping), permissions and detailed audit logging.

A common architectural pattern is the "Triple-Gate Pattern," which provides defense-in-depth across the AI layer, the MCP layer, and the API layer. This pattern is critical for mitigating risks such as prompt injection or unauthorized access to protected health information (PHI). Gateways also enable "Virtual MCP Servers," which expose only the minimum required tools to specific teams, enforcing the principle of least privilege at the infrastructure level.

Data Monetisation and the Rise of Research Collaboratives

The transition to a data foundry model allows health systems to convert their vast stores of patient records into active enablers for pharmaceutical and medtech innovation. This is often realised through large-scale research partnerships and the creation of data collaboratives.

The Truveta Model: Scale and Representation

One of the most prominent examples of the clinical data foundry in action is Truveta, a collaborative governed by 28 leading US health systems, including Northwell, Providence, and Trinity Health. Truveta’s platform aggregates de-identified medical records, imaging and genomics from billions of data points, representing more than 15% of all care delivered across 40 states in the U.S..

The Truveta model is built on "data stewardship," where member providers share normalised data that is then made accessible to life sciences researchers through a "Trusted Research Environment". This enables researchers to execute full studies and produce audit-ready evidence aligned to regulatory standards in minutes rather than months. The platform’s ability to standardise diverse medical terminology, such as the hundreds of ways COVID-19 might be coded—is a key differentiator that allows for high-fidelity cohort discovery.

The Mayo Clinic Platform: Transformation and Performance

The Mayo Clinic has also established itself as a leader in the data foundry movement. The Mayo Clinic Platform focuses on creating value through licensing, transactional revenue and equity growth, rather than just simple data sales. By 2024, the platform had reached over 45 million people, contributing to an operating revenue of $17.9 Billion for the clinic.

Mayo Clinic Financial Metric (2024)	Value	Strategic Significance
Total Revenue	$17.9 Billion	Reflects the scale of a world-class health system.
Net Operating Income	$1.1 Billion	Provides the "mission-sustaining" 6% margin required for innovation.
Research and Education Investment	$1.343 Billion	High reinvestment into the clinical data foundation.
Capital Expenditures	$1.38 Billion	Funding for physical and digital infrastructure expansions.

Mayo Clinic’s strategy involves "know-how" agreements, where collaborators gain access to the expertise of world-class physicians to refine their technologies. This approach moves the health system further up the value chain, from a data provider to a strategic R&D partner.

Acceleration of Clinical Trials and Drug Discovery

The core promise of the clinical data foundry is the acceleration of drug discovery through real-world evidence (RWE). Platforms like Truveta and the Mayo Clinic Platform provide a "complete, living view" of patient care that supports every stage of the therapeutic lifecycle.

Discovery: Researchers use the foundry to identify new biological targets and train AI models using real-time clinical information.
Clinical Trials: Data foundries allow for the precision recruitment of eligible patients and the simulation of trials using RWE to refine protocols.
Regulatory Submission: The production of high-fidelity, longitudinal data allows for the creation of "intelligent evidence" that meets FDA standards for post-market safety and efficacy studies.

Recent applications of these platforms include studies on GLP-1 medications (e.g., Wegovy), where researchers analysed prescribing patterns and patient demographics following FDA approval to understand early uptake and adherence.Similarly, the CDC has leveraged data from these foundries to analyse COVID-19 hospitalisation risks and antiviral prescribing patterns in older adults.

De-identification: The Technical and Regulatory Balancing Act

For a health system to function as a data foundry, it must master the process of de-identification, the removal of identifying information to mitigate privacy risks while supporting secondary use. This process is governed by strict frameworks, such as the HIPAA Privacy Rule in the United States and GDPR in Europe.

HIPAA De-identification Methods

The HIPAA Privacy Rule provides two primary methods for designating health information as de-identified:

Safe Harbour Method: This involves the removal of 18 specific categories of identifiers, including names, geographic details (smaller than state), and all dates except years. While easier to automate, it can lead to significant information loss.
Expert Determination Method: A qualified statistical expert applies scientific principles to determine that the risk of re-identification is very small. This method often preserves more data utility but requires significant human resources.

Automating the De-identification of Unstructured Clinical Notes

A major challenge for clinical data foundries is the de-identification of physician notes, which contain rich contextual details often locked in narrative free-text. Manual redaction is prohibitively expensive, leading to the development of robust, scalable NLP pipelines.

Software like Philter V1.0, developed at UCSF, represents the state-of-the-art in this domain. Philter addresses the limitations of off-the-shelf tools by using a combination of regular expressions and Named Entity Recognition (NER) to capture patient names that are also common English words, while "rescuing" valid genomic and pathology terms that might otherwise be redacted.

De-identification Solution	Cost per 1 Million Documents	Performance/Trade-off
John Snow Labs (Healthcare NLP)	$2,418	Highly scalable; infrastructure-agnostic.
Azure Health Data Services	$13,125	Integrated with cloud-native healthcare APIs.
Amazon Comprehend Medical	$14,525	Ease of use within AWS ecosystem.
OpenAI GPT-4o	$21,400	Superior contextual understanding but higher cost.

The cost of de-identifying a large clinical dataset is a significant operational consideration for a data foundry. For example, de-identifying 1 Million clinical documents can range from approximately $2,400 using specialised NLP infrastructure to over $21,000 using general-purpose large language models (LLMs).

Imaging and Genomics: The New Frontier of Anonymisation

As data foundries expand to include medical imaging and genomics, the technical requirements for privacy preservation increase. In medical imaging (DICOM format), PHI is found not just in metadata tags but often "burnt-in" to the pixel data itself. Tools like ScaleCapacity’s PixelGuard use AI-driven OCR to redact this text, while additional techniques like "skull-stripping" remove the skull from brain scans to prevent facial reconstruction, which can lead to re-identification.

Genomic data poses the greatest challenge, as a person's genetic sequence is inherently unique. Traditional k-anonymity, where every individual record is indistinguishable from at least k-1 others, is virtually impossible to achieve in genomic research without destroying the data's utility. This is driving interest in "differential privacy," which provides a mathematically rigorous "privacy budget" (epsilon) to bound the information leakage from any query, regardless of the adversary's background knowledge.

Public Sector Models: The NHS Secure Data Environment (SDE)

While the private sector in the US focuses on commercial licensing, the UK’s National Health Service (NHS) is developing a public-sector version of the clinical data foundry through its Research Secure Data Environment (SDE) network.

The "Data Access" Paradigm

The NHS SDE model represents a fundamental shift from "data sharing" (where copies of data are given to researchers) to "data access" (where researchers come to the data). This centralised approach allows for much higher standards of security and auditing.

The SDE network is built on the "Five Safes" framework:

Safe People: Researchers are trained and authorised.
Safe Projects: Research is approved for public benefit.
Safe Settings: Data remains within a secure "box" like Databricks or R Studio.
Safe Data: Identifiable fields are pseudonymised or removed.
Safe Outputs: An "escrow" function ensures that only non-disclosive, aggregated results can be exported.

This model addresses the public's concern over data being "sold" to private companies. By keeping the data within the NHS perimeter and granting access only for specific, time-limited research questions, the SDE network aims to build public trust while still enabling advanced innovation.

SDE Feature	Implementation Detail
Data Hosting	Secure NHSE-managed Amazon Web Services (AWS) accounts.
Access Control	2FA browser-based login; auditable via Immuta.
Analytical Tools	Support for GitLab, R Studio, STATA, and Databricks.
Regional Collaboration	North West SDE links three Integrated Care Boards (ICBs).

Public Perception and the Social License to Operate

The success of the clinical data foundry depends entirely on a "social license", the public's willingness to allow their health information to be used for research and commercial purposes. Recent studies highlight significant variations in public sentiment across different regions and demographics.

The Trust Gap

A 2021 study in the UK found that while 77.9% of patients were comfortable sharing their health data with the NHS, and 65.7% with universities, only 26.4% were comfortable sharing it with commercial technology companies. This trust gap is a major risk for the data foundry model, as partnerships with "Big Tech" and Pharma are essential for the monetisation and research objectives.

In Germany and Poland, cross-sectional surveys show that while patients generally believe AI can reduce medical complications (58%), they also view digitalisation as a potential risk factor (49%).

Sociodemographic variables are key: female, older, and less educated individuals are often more skeptical of digital health innovations.

Managing the Narrative Arc

Historical data from 2015 to 2024 suggests that discourse surrounding medical policy is often dominated by negativity in its early phases, which can lead to accelerated backlash and forced public hearings. To mitigate this, policy architects and health system CEOs are encouraged to adopt a strategy of "radical transparency".

Strategic best practices for trust-building include:

Proactive Engagement: Releasing official communications within the first 24 hours of a crisis can reduce misinformation by up to 45%.
AI-Driven Social Listening: Real-time monitoring of digital conversations allows systems to address rising tensions before they evolve into protests.
Platform-Specific Framing: Adjusting messages for different demographics (e.g., short-form video on TikTok for younger audiences vs. detailed leaflets for older ones).

Conclusion: Strategic Recommendations for Health System Leaders

As health systems move toward the 2030 horizon, the transition to a clinical data foundry is no longer optional; it is a structural necessity for financial and operational survival. The analysis suggests several critical actions for CEOs and boards:

Prove it, then scale it: Start with domains where AI can deliver immediate ROI, such as documentation or revenue cycle management, before expanding into complex research partnerships.
Build for the end state: Treat existing point solutions as temporary on-ramps. All digital investments should be designed with a modular, interoperable AI platform in mind.
Establish rigorous data governance: This includes not just technical security but the creation of data catalogs, clear data rights, and transparent sharing agreements that can be defended in the public arena.
Signal scale readiness: Potential research partners will gravitate toward organisations that can demonstrate multisite rollout capabilities and a commitment to the highest standards of de-identification and ethical data use.

The clinical data foundry represents the next stage of healthcare’s digital evolution. By converting the passive record into an active asset, health systems can bridge the gap between financial sustainability and the urgent need for medical innovation, ultimately improving outcomes for the millions of patients they serve.

Nelson Advisors > European MedTech and HealthTech Investment Banking

Nelson Advisors specialise in Mergers and Acquisitions, Partnerships and Investments for Digital Health, HealthTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies. www.nelsonadvisors.co.uk

Nelson Advisors regularly publish Thought Leadership articles covering market insights, trends, analysis & predictions @ https://www.healthcare.digital

Nelson Advisors publish Europe’s leading HealthTech and MedTech M&A Newsletter every week, subscribe today! https://lnkd.in/e5hTp_xb

Nelson Advisors pride ourselves on our DNA as ‘Founders advising Founders.’ We partner with entrepreneurs, boards and investors to maximise shareholder value and investment returns. www.nelsonadvisors.co.uk

#NelsonAdvisors #HealthTech #DigitalHealth #HealthIT #Cybersecurity #HealthcareAI #ConsumerHealthTech #Mergers #Acquisitions #Partnerships #Growth #Strategy #NHS #UK #Europe #USA #VentureCapital #PrivateEquity #Founders #SeriesA #SeriesB #Founders #SellSide #TechAssets #Fundraising #BuildBuyPartner #GoToMarket #PharmaTech #BioTech #Genomics #MedTech